Biotech RadarJobs updated

COMPANY

Science

HQ: Alameda, CA source · science.xyz ↗

FDA-cleared device company

Location: Alameda, CA · source · Oct 14, 2026

Profile checked Oct 10, 2026

Keywords: Dry Age-related Macular Degeneration Stargardt Disease Retinitis Pigmentosa Inherited Retinal Degeneration Geographic Atrophy PRIMA Bionic Vision System PRIMA Products

4Trials (company is sponsor)

Funding and NIH signals

Job counts as of Oct 18, 2026. All funding and NIH signals

Raises and deals from press releases

Raises announced in these releases: $230M disclosed.

From the company’s own releases; this list is partial. All raises and deals

Timeline

  1. Trial start Not phased (device or behavioral study): Restoration of Central Vision With PRIMA in Patients With Photoreceptor Degeneration source ↗
  2. Raise Series C · $230M source ↗
  3. Trial start Not phased (device or behavioral study): Restoration of Central Vision With the PRIMA System in Patients With Atrophic AMD source ↗
  4. Trial start Not phased (device or behavioral study): PRIMA US-Feasibility Study in Atrophic Dry AMD source ↗
  5. Trial start Not phased (device or behavioral study): Feasibility Study of Compensation for Blindness With the PRIMA System in Patients With Dry Age Related Macular Degeneration source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 4

RecordTitlePhaseStatusStartPrimary completion
NCT07266584Restoration of Central Vision With PRIMA in Patients With Photoreceptor DegenerationNot phased (device or behavioral study)RecruitingApr 22, 2026Mar 1, 2029 (estimated)
NCT03392324PRIMA US-Feasibility Study in Atrophic Dry AMDNot phased (device or behavioral study)CompletedApr 26, 2018May 20, 2026 (actual)
NCT04676854Restoration of Central Vision With the PRIMA System in Patients With Atrophic AMDNot phased (device or behavioral study)Active, not recruitingNov 24, 2020Feb 1, 2024 (actual)
NCT03333954Feasibility Study of Compensation for Blindness With the PRIMA System in Patients With Dry Age Related Macular DegenerationNot phased (device or behavioral study)CompletedNov 6, 2017Dec 12, 2024 (actual)
Feedback